PEMT and liver disorder: The PE N-methyltransferase (PEMT) pathway uses SAMe to methylate PE yielding PC and being affected by both SAMe increase and depletion which ultimately can lead to dysregulation of VLDL secretion and result in liver disease, atherosclerosis and obesity [38,39,40].